id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2021-N-0002-0045,FDA,FDA-2021-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Rule,Final Rule,2022-03-29T04:00:00Z,2022,3,2022-03-29T04:00:00Z,,2022-03-29T13:38:19Z,2022-06395,0,0,0900006484feb0a8 FDA-2021-N-0002-0044,FDA,FDA-2021-N-0002,New Animal Drugs; Withdrawal of Approval of New Animal Drug Application,Notice,Withdrawal,2022-02-28T05:00:00Z,2022,2,2022-02-28T05:00:00Z,,2022-02-28T16:29:16Z,2022-03539,0,0,0900006484fab908 FDA-2021-N-0002-0043,FDA,FDA-2021-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of a New Animal Drug Application; Change of Sponsor,Rule,Final Rule,2022-02-28T05:00:00Z,2022,2,2022-02-28T05:00:00Z,,2022-02-28T16:22:14Z,2022-03538,0,0,0900006484fab3c6 FDA-2021-N-0002-0037,FDA,FDA-2021-N-0002,FOI Summary oA 200-708 approved August 2 2021,Supporting & Related Material,Background Material,2022-02-25T05:00:00Z,2022,2,,,2022-02-25T13:45:46Z,,0,0,0900006484fa0eea FDA-2021-N-0002-0041,FDA,FDA-2021-N-0002,FOI Summary sN 141-063 approved August 19 2021,Supporting & Related Material,Background Material,2022-02-25T05:00:00Z,2022,2,,,2022-02-25T13:46:01Z,,0,0,0900006484fa0ef2 FDA-2021-N-0002-0042,FDA,FDA-2021-N-0002,FOI Summary oN 141-545 approved July 15 2021,Supporting & Related Material,Background Material,2022-02-25T05:00:00Z,2022,2,,,2022-02-25T13:46:05Z,,0,0,0900006484fa0ef5 FDA-2021-N-0002-0040,FDA,FDA-2021-N-0002,FOI Summary oA 200-709 approved August 18 2021,Supporting & Related Material,Background Material,2022-02-25T05:00:00Z,2022,2,,,2022-02-25T13:45:57Z,,0,0,0900006484fa0ef0 FDA-2021-N-0002-0038,FDA,FDA-2021-N-0002,FOI Summary sA 200-618 approved August 16 2021,Supporting & Related Material,Background Material,2022-02-25T05:00:00Z,2022,2,,,2022-02-25T13:45:50Z,,0,0,0900006484fa0eed FDA-2021-N-0002-0039,FDA,FDA-2021-N-0002,FOI Summary oA 200-703 approved July 7 2021,Supporting & Related Material,Background Material,2022-02-25T05:00:00Z,2022,2,,,2022-02-25T13:45:53Z,,0,0,0900006484fa0eee FDA-2021-N-0002-0029,FDA,FDA-2021-N-0002,FOI Summary sN 141-452 approved May 18 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:01Z,,0,0,0900006484e31b69 FDA-2021-N-0002-0032,FDA,FDA-2021-N-0002,FOI Summary oA 200-702 approved April 23 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:19Z,,0,0,0900006484e31b6c FDA-2021-N-0002-0035,FDA,FDA-2021-N-0002,FOI Summary oN 141-543 approved June 1 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:37Z,,0,0,0900006484e356c9 FDA-2021-N-0002-0024,FDA,FDA-2021-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Rule,Final Rule,2021-11-08T05:00:00Z,2021,11,2021-11-08T05:00:00Z,,2021-11-08T14:01:16Z,2021-24075,0,0,0900006484e35459 FDA-2021-N-0002-0027,FDA,FDA-2021-N-0002,FOI Summary oA 200-700 approved June 10 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:50:45Z,,0,0,0900006484e31b67 FDA-2021-N-0002-0036,FDA,FDA-2021-N-0002,FOI Summary sN 140-269 approved May 25 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:43Z,,0,0,0900006484e356ca FDA-2021-N-0002-0028,FDA,FDA-2021-N-0002,FOI Summary sN 128-620 approved June 14 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:50:51Z,,0,0,0900006484e31b68 FDA-2021-N-0002-0026,FDA,FDA-2021-N-0002,FOI Summary oA 200-697 approved April 5 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:50:39Z,,0,0,0900006484e31b66 FDA-2021-N-0002-0030,FDA,FDA-2021-N-0002,FOI Summary sN 141-528 approved April 12 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:07Z,,0,0,0900006484e31b6a FDA-2021-N-0002-0031,FDA,FDA-2021-N-0002,FOI Summary oA 200-706 approved June 28 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:13Z,,0,0,0900006484e31b6b FDA-2021-N-0002-0033,FDA,FDA-2021-N-0002,FOI Summary sN 139-189 approved April 26 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:25Z,,0,0,0900006484e31b6d FDA-2021-N-0002-0025,FDA,FDA-2021-N-0002,FOI Summary oA 200-701 approved June 10 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:50:04Z,,0,0,0900006484e31b65 FDA-2021-N-0002-0034,FDA,FDA-2021-N-0002,FOI Summary oA 200-704 approved June 14 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address,Supporting & Related Material,Background Material,2021-11-08T05:00:00Z,2021,11,,,2021-11-08T14:51:31Z,,0,0,0900006484e356c8 FDA-2021-N-0002-0023,FDA,FDA-2021-N-0002,FOI Summary cN 141-526 approved January 11 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:52Z,,0,0,0900006484de3d1c FDA-2021-N-0002-0006,FDA,FDA-2021-N-0002,FOI Summary oA 200-675 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:51Z,,0,0,0900006484de3d16 FDA-2021-N-0002-0010,FDA,FDA-2021-N-0002,FOI Summary sN 141-336 approved January 7 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:52Z,,0,0,0900006484de3d1b FDA-2021-N-0002-0016,FDA,FDA-2021-N-0002,FOI Summary oN 141-539 approved January 15 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:54Z,,0,0,0900006484de3d22 FDA-2021-N-0002-0017,FDA,FDA-2021-N-0002,FOI Summary sN 132-872 approved March 24 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:54Z,,0,0,0900006484de3d23 FDA-2021-N-0002-0018,FDA,FDA-2021-N-0002,FOI Summary oN 141-531 approved March 19 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:54Z,,0,0,0900006484de3d24 FDA-2021-N-0002-0020,FDA,FDA-2021-N-0002,FOI Summary oA 200-683 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:55Z,,0,0,0900006484de3d30 FDA-2021-N-0002-0004,FDA,FDA-2021-N-0002,FOI Summary oA 200-677 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:51Z,,0,0,0900006484de3d14 FDA-2021-N-0002-0008,FDA,FDA-2021-N-0002,FOI Summary oA 200-657 approved February 18 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:51Z,,0,0,0900006484de3d18 FDA-2021-N-0002-0011,FDA,FDA-2021-N-0002,FOI Summary oA 200-699 approved March 11 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:53Z,,0,0,0900006484de3d1d FDA-2021-N-0002-0015,FDA,FDA-2021-N-0002,FOI Summary oA 200-685 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:54Z,,0,0,0900006484de3d21 FDA-2021-N-0002-0013,FDA,FDA-2021-N-0002,FOI Summary oA 200-678 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:53Z,,0,0,0900006484de3d1f FDA-2021-N-0002-0009,FDA,FDA-2021-N-0002,FOI Summary oA 200-684 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:52Z,,0,0,0900006484de3d1a FDA-2021-N-0002-0005,FDA,FDA-2021-N-0002,FOI Summary oA 200-676 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:51Z,,0,0,0900006484de3d15 FDA-2021-N-0002-0002,FDA,FDA-2021-N-0002,FOI Summary oA 200-625 approved March 22 2021 re: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:50Z,,0,0,0900006484de3d12 FDA-2021-N-0002-0007,FDA,FDA-2021-N-0002,FOI Summary cN 141-544 approved January 14 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:51Z,,0,0,0900006484de3d17 FDA-2021-N-0002-0003,FDA,FDA-2021-N-0002,FOI Summary oA 200-666 approved February 18 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:51Z,,0,0,0900006484de3d13 FDA-2021-N-0002-0022,FDA,FDA-2021-N-0002,FOI Summary oA 200-506 approved February 16 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:51Z,,0,0,0900006484de3d19 FDA-2021-N-0002-0012,FDA,FDA-2021-N-0002,FOI Summary sA 200-466 approved February 8 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:53Z,,0,0,0900006484de3d1e FDA-2021-N-0002-0014,FDA,FDA-2021-N-0002,FOI Summary oN 141-540 Approved February 26 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:53Z,,0,0,0900006484de3d20 FDA-2021-N-0002-0019,FDA,FDA-2021-N-0002,FOI Summary oN 141-530 approved March 15 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:55Z,,0,0,0900006484de3d25 FDA-2021-N-0002-0021,FDA,FDA-2021-N-0002,FOI Summary oA 200-686 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Supporting & Related Material,Background Material,2021-10-22T04:00:00Z,2021,10,,,2021-10-26T14:36:55Z,,0,0,0900006484de3d31 FDA-2021-N-0002-0001,FDA,FDA-2021-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship,Rule,Final Rule,2021-10-20T04:00:00Z,2021,10,2021-10-20T04:00:00Z,,2021-10-20T15:15:02Z,2021-22604,0,0,0900006484dcea30